E-Mail Newsletter (MLL News)

Our newsletter is an offer of MLL Münchner Leukämielabor GmbH, Max-Lebsche-Platz 31, 81377 Munich (“MLL,” “we”) and contains information about our products and services, research results, events and other news relevant to the company and to the discipline, especially regarding diagnostics and subsequent therapy for leukemia and lymphoma. For you to subscribe, we need the e-mail address that you want us to send the newsletter to. We may use optional information to personalize how the addressee is addressed.
To continuously improve the quality of our newsletter and its contents, we conduct a pseudonymized analysis of the opening rate of the newsletter and information on calling up specific articles. You can find detailed information on how personal data is processed in connection with our newsletter in our Data protection information section.

By clicking on the “Subscribe to the newsletter” button, I consent to allow MLL to use the e-mail address and optional information provided by me for sending the newsletter and for addressing me personally.


Newsletter registration

You have the right to withdraw your consent at any time. Withdrawing your consent does not affect the lawfulness of the processing that took place based on your consent up until the time of withdrawal. One way you can withdraw your consent is by using the withdrawal function contained in every newsletter. Alternatively, you can declare that you are withdrawing your consent by sending an e-mail to or by mailing a letter to MLL Münchner Leukämielabor GmbH, Max-Lebsche-Platz 31, 81377 Munich.

MLL Magazine

Stay up to date

Here you will find all MLL News as well as scientific contributions to leukemia diagnostics and research.

to the MLL Magazine

Current Articles

  • Dr. med. Christian Pohlkamp
    from 20.12.2019
    MLL News
    Munich Leukemia Laboratory Developing a Digital Order Entry Platform

    In this digital age, MLL has now set up a way to enter orders online. Following an extensive beta testing phase in the outpatient area, it is now possible to use a corresponding digital platform free of charge.

    Post review
    Read article
  • Prof. Dr. med. Dr. phil. Torsten Haferlach
    from 20.12.2019
    MLL News
    Successful Participation by MLL in the ASH Conference in Orlando

    This year as well, several MLL scientists took advantage of the ASH (American Society of Hematology) in Orlando to get an overview of the current research emphases and future developments. They also gave a number of lectures there and presented a large number of posters.

    Post review
    Read article


20.04.2020 - 24.04.2020
MLL Academy 2020

The next MLL Academy will be held from April 20th until April 24th, 2020. During the five-day workshop on the subject of “state of the art diagnostics in hematological malignancies“, participants can expect a mix of theoretical and practical content as well as joint discussions, all concerning the diagnosis of leukemias and lymphomas.

Read more


Kristina von Sayn-Wittgenstein

MLL Münchner Leukämielabor GmbH
Max-Lebsche-Platz 31
81377 München

T: +49 (0)89 99017-506

Getting here